Basic Information
ID DDInter1737
Drug Type small molecule
Molecular Formula C14H7Cl2NO3
Molecular Weight 308.116
CAS Number 594839-88-0
Description Tafamidis and tafamidis meglumine (FX-1006A) are benzoxazole derivatives[A27206] developed by FoldRX.[A189717] Tafamidis is structurally similar to diflusinal.[A189717] Tafamidis was granted an EMA market authorisation on 16 November 2011[L6247] and FDA approval on 3 May 2019.[L11280]
ATC Classification N07XX08
IUPAC Name 2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid
InChI TXEIIPDJKFWEEC-UHFFFAOYSA-N
Canonical SMILES OC(=O)C1=CC=C2N=C(OC2=C1)C1=CC(Cl)=CC(Cl)=C1
Useful Links DrugBank ChEBI PubChem Substance KEGG Drug ChemSpider BindingDB Wikipedia ChEMBL ZINC
Interactions with Tafamidis
Filter:
Severity level ID Name Mechanism Detail
Interactions with diseases
Filter:
Severity level Disease name Text References
Interactions with foods
Filter:
Severity level Food name Description Management Mechanism References
Interactions with compound preparation
Multi-DRUG trade Multi-DRUG Drug type Warning Note